Lifelong supplementation reduced midlife mortality risk in mice

Maintaining and improving prime of beingness (QOL) and extending a steadfast lifespan are among the astir important objectives for an aging society. A probe radical led by Dr. Keiko Odera and Dr. Ryoya Takahashi, a erstwhile professor, from the Department of Biochemistry, Faculty of Pharmaceutical Sciences, has revealed that lifelong supplementation with PQQ and its derivative IPQ successful senescence-accelerated rodent (SAM) P8 mice reduces mortality hazard during midlife and delays the progression of aging and age-related diminution successful muscular function.